NCT04391478View on ClinicalTrials.gov

Efficacy and Safety of Milrinone Versus Sildenafil in the Treatment of Neonates With Persistent Pulmonary Hypertension

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

April 30, 2015

Study Completion Date

September 30, 2015

Conditions
Persistent Pulmonary Hypertension
Interventions
DRUG

Milrinone

milrinone lactate, 1mg/ml, for intra venous use only

DRUG

Sildenafil

50mg sildenafil citrate/tablet, crushed in water taken by nasogastric tube

All Listed Sponsors
lead

Rania Ali El-Farrash

OTHER

NCT04391478 - Efficacy and Safety of Milrinone Versus Sildenafil in the Treatment of Neonates With Persistent Pulmonary Hypertension | Biotech Hunter | Biotech Hunter